J Curr Pediatr. 2025;23(3):172-180
DOI: 10.4274/jcp.2025.90958
Tuhan H, Singin B, Donbaloğlu Z, Özdem S, Parlak M. Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children? J Curr Pediatr. 2025;23(3):172-180
The errors were made inadvertently by the authors.
The funding information was inadvertently omitted from the final published version of the article.
The funding statement was included in the initially submitted manuscript but was removed from the blinded version during the double-blind peer-review process. However, it was inadvertently not reinserted into the final version of the manuscript.
The Financial Disclosure statement was published as follows:
The authors declared that this study received no financial support.
The Financial Disclosure statement should be corrected as follows:
This research was funded by the Scientific Research Projects Coordination Unit of Akdeniz University (project no. TSA-2023-6059).
